United States
Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
Philippines
South Africa
United Kingdom
Clinical Pharmacology Podcast with Nathan Teuscher
Similar topics: drug and development
Science
Conversations in Drug Development
by Boyds
Today: #198 in Science, Brazil on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · New Zealand
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Conversations in Drug Development, try…
Autism Weekly Podcast
Similar topics: forefront and clinicians
The Naked Scientists Podcast
Also in Science
The Development Podcast
Similar topics: development and cutting
ImmunoTea: Your Immunology Podcast
Also in Science
Approved
Also in Science
Ranking history · New Zealand
No ranking history for this show in New Zealand over the last 7 days.
Latest episodes
-
Ada Lovelace Day: Breaking Barriers, Shaping Futures
October 13, 2026 · 18 minTo celebrate Ada Lovelace Day, women from Boyds share their career journeys, the challenges they’ve overcome and their advice for the next generation of women in science.
-
EU Pharma Reform 2026: What Every Developer Needs to Know
October 7, 2026 · 38 minIn this episode, Katherine Bowen and Shalini Gupta discuss the EU pharmaceutical legislation reform — a comprehensive update to regulations and directives that will affect drug approval, orphan and paediatric rules, exclusivity incentives…
-
Live Biotherapeutics: Navigating the Next Frontier in Drug Development
June 22, 2026 · 32 minIn this episode, Boyds' experts explore the emerging field of live biotherapeutic products (LBPs), explaining what they are, how they differ from everyday probiotics, and their roots in microbiome-based therapies, including fecal…
-
UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025
April 8, 2026 · 26 minIn this episode, experts at Boyds, Chris Moore and Shalini Gupta break down the UK Clinical Trial Regulation (UK CTR), exploring why the reform was introduced and highlighting the practical changes sponsors need to know - including new…
-
How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?
March 10, 2026 · 30 minIn this episode of Conversations in Drug Development, host Harriet Edwards is joined by Kelsey Lennoch and Eamon McGowran to discuss the EU Biotech Act, a major regulatory proposal aimed at revitalizing Europe’s biotech sector. They…
Show 7 more episodesShow fewer episodes
-
Navigating the FDA Landscape: More Changes, and What's Next?
October 23, 2025 · 27 minIn this episode, Eric Hardter and guest Kelsey Lenoch discuss recent US FDA developments, including leadership changes at CBER and CDER, staffing impacts on orphan product reviews, and the new Rare Disease Evidence Principles aimed at…
-
At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development
August 26, 2025 · 40 minIn this special episode of Conversations in Drug Development, host Harriet Edwards sits down with Professor Alan Boyd, founder and CEO of Boyds, to reflect on the company’s remarkable 20-year journey in drug development. Professor Boyd…
-
Navigating the New FDA Landscape: Opportunities and Challenges Ahead
July 15, 2025 · 36 minIn the latest episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Eric Hardter discuss the ever-changing US regulatory landscape under the new administration, including new leadership and staff turnover, and their…
-
From Lab to Launch – Avoiding the Pitfalls of Drug Development
May 29, 2025 · 28 minIn this episode, Dr Neil Fish and Dr Ami Patel dive into the real-world challenges of drug development - from early-stage planning to regulatory hurdles and everything in between. Drawing on decades of experience, they share personal…
-
Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025
March 17, 2025 · 33 minIn this episode, Harriet Edwards from Boyds hosts a discussion on 2025 predictions in drug development and regulatory affairs. Joined by regulatory experts Dr. Katherine Bowen and Dr. Eric Hartder, the conversation covers the anticipated…
-
How to Effectively De-Risk your IND Process
February 11, 2025 · 53 minIn this episode, Dr. Nick Meyers and Dr. Eric Hardter, discuss effective strategies for de-risking Investigational New Drug (IND) applications. Discover key insights on how to navigate the complexities of IND submissions, including the…
-
Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators
January 7, 2025 · 24 minIn this episode, host Harriet Edwards is joined by Eamonn McGowran, an expert in medical device regulations, to explore the complex and rapidly evolving regulatory landscape for medical devices, particularly within the EU. Eamonn…
About the show
Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.